Page 2877 - Cote clinical veterinary advisor dogs and cats 4th

1524 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

Corticosteroid-responsive meningomyelitis. See Steroid- Culture. See Bacterial culture and sensitivity; Blood Cyclosporine (Continued)
culture; Fungal culture
responsive meningitis-arteritis Cuprimine. See D-Penicillamine for hepatitis, chronic idiopathic, 454
Corticosteroid-responsive tremor syndrome, 530
for immune-mediated hemolytic anemia, 62
VetBooks.ir Cortisol, serum, 1328–1329 Cushing’s disease. See Hyperadrenocorticism for inflammatory bowel disease, 545
Cushing’s reflex, 1047.e1
for intestinal pseudo-obstruction, 557.e2
Cortisol assay, glucocorticoid cross-reactivity with, 1329,
Cutaneous adverse drug reaction (CADR), 227–228
for keratoconjunctivitis sicca, 569
1361
Cortisol/creatinine ratio, urine, 486, 1391
Cortisone, 1510.e7t Cutaneous adverse food reaction (CAFR), 345 for lymphoplasmacytic rhinitis, 891
Cutaneous and renal glomerular vasculopathy of
for pannus, 749
Corynebacterium spp., infective endocarditis and, 295 greyhounds. See Hemolytic-uremic syndrome for pemphigus complex, 771
Cosequin. See Glucosamine-chondroitin sulfate Cutaneous cysts, 228.e2–228.e3, 228.e2f–228.e3f, 629. for perianal fistula, 772
Cosmegen. See Actinomycin D See also Pilonidal cyst for pure red cell aplasia and nonregenerative anemia,
Cosyntropin, 1460 Cutaneous diseases. See Dermatitis; Dermatoses; Skin 64
Coton de Tuléa disorders for sebaceous adenitis, 902
cerebellar cortical degeneration in, 149.e3 Cutaneous distribution serum levels of, 1333–1334
retinal detachment in, 885 of forelimb nerves, 1257 for stomatitis, 944
Cough, 136–138, 217–218, 1172.e5, 1209 of hindlimb nerves, 1258 systemic, administration and dosage of, 1466
vomiting and, 217 Cutaneous draining tracts, 275.e2–275.e4, 275.e3f Cyproheptadine
“Cough-drop” phenomenon. See Tussive syncope Cutaneous histiocytosis, 473 administration and dosage of, 1200t–1201t, 1466
Cough suppressants. See Antitussive therapy Cutaneous larval migrans, 480.e2 for amphetamine toxicosis, 50
Coumadin. See Warfarin Cutaneous lupus erythematosus, 228–229, 229f, 676 for anorexia, 68, 746, 1007
Coupage, 1134–1135 Cutaneous lymphoma, 604.e5–604.e6 for antidepressant drug toxicosis, 71
Covera. See Verapamil Cutaneous masses, 628–629 for feline asthma, 85
Cowdry type A inclusion bodies, 454.e2 nonneoplastic, 1211 for hops toxicosis, 481
COX-2, 624, 829 Cutaneous mast cell tumor, 632–634 for mast cell tumor, 634
Coxofemoral luxation. See Hip luxation Cutaneous melanoma, 644–645, 1437a for opiates/opioids toxicosis, 711
Cozaar. See Losartan Cutaneous neoplasia, 230–231, 230f, 230.e1f, 1211 Cyromazine, 551.e2t
CPIV. See Canine parainfluenza virus (CPIV) Cutaneous nerve distribution Cyst
CPK (creatine phosphokinase). See Creatine kinase (CK) forelimb, 1257 cutaneous, 629. See also Pilonidal cyst
cPLI. See Canine pancreatic lipase immunoreactivity hindlimb, 1258 dentigerous, 712
(cPLI) Cutaneous papillomas, 752–754, 753f meibomian gland, 318
CPR. See Cardiopulmonary cerebral resuscitation Cutaneous paraneoplastic syndromes, 756.e2f ovarian follicular, 822
Crackles, 837 Cutaneous sporotrichosis lesions, 938 pilonidal/dermoid, 788.e3–788.e4, 788.e4f
Cranial cruciate ligament (CrCL) Cutaneous ulcer, 275.e1 renal. See Polycystic kidney disease (PKD)
injury of, 218–221, 219f, 220.e1f–220.e2f Cutaneous vasculitis, 1031–1032 tonsillar, 979
hip dysplasia and, 470 Cutaneous vasculopathy, 1031–1033, 1032f uveal, 1023.e2–1023.e3, 1023.e2f
instability of, 763 Cuterebra, 293 Cystadenoma, hepatobiliary, 232.e3–232.e4, 446
Cranial drawer sign, 219, 1144 myiasis, 674 Cysteine. See Cystine crystals; Cystine urolithiasis
Cranial nerves nodular skin disorders and, 694 Cystic calculi. See Urolithiasis
deficits, 1210 Cyanide toxicosis, smoke inhalation and, 920 Cystic endometrial neoplasia, 854
evaluation of, 1137 Cyanobacteria toxicosis. See Blue-green algae toxicosis Cystic mucinous hyperplasia of the gallbladder, 374
in ophthalmic examination, 1137 Cyanocobalamin. See Cobalamin Cystine crystals, 1290, 1332f
Cranial vena cava (CrVC) syndrome, 221–222 Cyanosis Cystine urolithiasis, 1014.e2–1014.e4, 1014.e2f–
Craniomandibular osteopathy, 716 causes of, 1211 1014.e3f
Craniotomy, for head trauma, 405 diagnostic approach to, 1408a Cystitis, 110.e3
CrCL injury. See Cranial cruciate ligament (CrCL), differentiation of, 1212.e1 bacterial, 232–234, 1202.e1
injury of Cyanotic heart disease emphysematous, 234
Creatine kinase (CK), 1329 Eisenmenger’s syndrome, 288.e2 feline alopecia and, 46
Creatine phosphokinase (CPK). See Creatine kinase (CK) right–to-left shunting, 231 fungal/algal, 234.e2–234.e3
Creatinine, 1330 and syncope, 954 gallbladder. See Cholecystitis
in chronic kidney disease staging, 167 Cyanuric acid and melamine, in adulterated diets, 37t hemorrhagic, chemotherapy and, 152–153
Crenation, differentiation from acanthocytes, 1298 CyberKnife SRS, 308 Cystocentesis, 1085.e2–1085.e4, 1085.e2f
Crenosoma vulpis, 595 Cycad palm toxicosis, 737–738, 738.e1f for urethral obstruction, 802, 1011
Crepitus, subcutaneous emphysema and, 950.e2 Cycas revoluta, 737 Cystogram, 1085.e4–1085.e6, 1085.e5f–1085.e6f
Cribriform carcinoma, 621 Cyclic flank alopecia. See Recurrent flank alopecia in urachal diverticulum, 1007.e2f
Cricopharyngeal achalasia/dysphagia, 222–223 Cyclic thrombocytopenia, 232.e2–232.e3 Cystoisospora infection, 187, 830.e6
Cricopharyngeal asynchrony. See Cricopharyngeal Cyclin A, 621 Cystolithiasis. See Urolithiasis
achalasia/dysphagia Cyclitis. See Uveitis Cystopexy, for perineal hernia, 775
Cricopharyngeal myotomy/myectomy, 223 Cyclobenzaprine, 108 Cystorelin. See Gonadotropin-releasing hormone (GnRH)
Cross-matching of blood, 1084–1085, 1085f, 1330 Cyclooxygenase inhibitors. See also specific drugs Cystoscopy, 1085–1086, 1086.e1f
Crossbite, 617 and gastric ulcers, 382 Cystotomy, for urethral obstruction, 802
Cruciate ligament injury. See Cranial cruciate ligament toxicosis from, 696 Cytarabine, 1466
(CrCL), injury of Cyclophosphamide Cytauxzoon felis, 1172.e4t
Crusting skin disorders, 847–849. See also Cornification administration and dosage of, 1466 Cytauxzoonosis, 235–236, 235.e1f, 236f
disorders adverse reactions to, 152–154 Cytobin. See Triiodothyronine (T3)
diagnostic approach to, 1446a for aplastic anemia, 56 Cytologic analysis
differential diagnosis of, 1212.e2 for immune-mediated hemolytic anemia, 62 in blastomycosis, 122f
sebaceous adenitis and, 901–903, 902f, 903.e1f for lymphoma, 608 bone marrow, 1317–1318
CrVC syndrome. See Cranial vena cava (CrVC) syndrome for renal neoplasia, 877 in acute leukemia, 587
Cryoprecipitate for rheumatoid arthritis, 889 in coccidioidomycosis, 185–186
for hemophilia, 432 Cyclops spp. water flea, 928.e2 in cryptococcosis, 224f
for von Willebrand disease, 1044 Cyclosporine in cutaneous neoplasia, 230
Cryosurgery, for epulides, 308 administration and dosage of, 1466 ear, 1093–1094
Cryptococcosis, 223–225, 224f allergy testing and, 92 ear canal, 729
Cryptococcus antigen test, 1331 for alopecia, 48 fine-needle sampling for. See Fine-needle aspiration
Cryptococcus neoformans/Cryptococcus gatti species for aplastic anemia, 56 (FNA)
complex, 224 for atopic dermatitis, 93 in nodular skin disorders, 694
Cryptogenic organizing pneumonia, 553 for conjunctivitis, 201 rectal scraping for, 1157f
Cryptorchidism, 225.e2–225.e3 for cutaneous lupus erythematosus, 229 in round cell tumors, 894
Cryptosporidiosis, 225–226 for cutaneous vasculopathy, 1033 skin, 1091–1093
Crystal meth. See Amphetamine toxicosis for dermatomyositis, 246.e4 vaginal, 1183–1184, 1184f, 1184.e1f
Crystalloids, 1510.e8 for eosinophilic granuloma complex, 301 Cytomel. See Triiodothyronine (T3)
Crystalluria, 1331, 1332f for episcleritis/scleritis, 305 Cytopenia, 1068
CSF. See Cerebrospinal fluid (CSF) for erythema multiforme and toxic epidermal refractory. See Myelodysplasia
CSK. See Chronic superficial keratitis (CSK) necrolysis, 309.e3 Cytopoint, 93
CT. See Computed tomography (CT) for feline asthma, 85 Cytosar. See Cytosine arabinoside
www.ExpertConsult.com